↓ Skip to main content

Cochrane Database of Systematic Reviews

Ganoderma lucidum(Reishi mushroom) for cancer treatment

Overview of attention for article published in this source, June 2012
Altmetric Badge

Mentioned by

1 news outlet
11 tweeters
12 Facebook pages
2 video uploaders


75 Dimensions

Readers on

149 Mendeley
1 CiteULike
<i>Ganoderma lucidum</i>(Reishi mushroom) for cancer treatment
Published by
John Wiley & Sons, Ltd, June 2012
DOI 10.1002/14651858.cd007731.pub2
Pubmed ID

Jin, Xingzhong, Ruiz Beguerie, Julieta, Sze, Daniel Man-yeun, Chan, Godfrey CF


Ganoderma lucidum is a natural medicine that is widely used and recommended by Asian physicians and naturopaths for its supporting effects on immune system. Laboratory research and a handful of preclinical trials have suggested that G. lucidum carries promising anticancer and immunomodulatory properties. The popularity of taking G. lucidum as an alternative medicine has been increasing in cancer patients. However, there is no systematic review that has been conducted to evaluate the actual benefits of G. lucidum in cancer treatment.

Twitter Demographics

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
South Africa 1 <1%
Unknown 146 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 38 26%
Student > Bachelor 24 16%
Researcher 16 11%
Student > Ph. D. Student 10 7%
Other 9 6%
Other 24 16%
Unknown 28 19%
Readers by discipline Count As %
Medicine and Dentistry 50 34%
Agricultural and Biological Sciences 28 19%
Biochemistry, Genetics and Molecular Biology 10 7%
Nursing and Health Professions 10 7%
Psychology 6 4%
Other 18 12%
Unknown 27 18%